The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Worldwide burden of cancer attributable to HPV by site, country and HPV type
de Martel, C., Plummer, M., Vignat, J., & Franceschi, S. (2017) · International Journal of Cancer · doi:10.1002/ijc.30716 · Cited by 2,322
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Dürst, M., Gissmann, L., Ikenberg, H., & zur Hausen, H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3812 · Cited by 2,025
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Schwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483
Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions
Felfoul, O., Mohammadi, M., Taherkhani, S., de Lanauze, D., Zhong Xu, Y., Loghin, D., Essa, S., Jancik, S., Houle, D., Lafleur, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.137 · Cited by 1,106
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Bruni, L., Diaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F. X., de Sanjosé, S., & Castellsagué, X. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30099-7 · Cited by 824
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
Hawley‐Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., & Schiller, J. T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08570.x · Cited by 733
Detection and Characterization of Tumor Hypoxia Using pO 2 Histography
Vaupel, P., Höckel, M., & Mayer, A. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1628 · Cited by 728
Metabolic targets for cancer therapy
Galluzzi, L., Kepp, O., Heiden, M. G. V., & Kroemer, G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4145 · Cited by 711
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 660
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Mesri, E. A., Feitelson, M. A., & Munger, K. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.011 · Cited by 650
Jeon, S., & Lambert, P. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1654 · Cited by 527
Mitra, A., MacIntyre, D. A., Lee, Y. S., Smith, A., Marchesi, J. R., Lehne, B., Bhatia, R., Lyons, D., Paraskevaidis, E., Li, J. V., et al. (2015) · Scientific Reports · doi:10.1038/srep16865 · Cited by 498
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
Martinez-Zapien, D., Ruiz, F. X., Poirson, J., Mitschler, A., Ramirez, J., Forster, A., Cousido-Siah, A., Masson, M., Pol, S. V., Podjarny, A., et al. (2016) · Nature · doi:10.1038/nature16481 · Cited by 483
The concurrent chemoradiation paradigm—general principles
Seiwert, T. Y., Salama, J. K., & Vokes, E. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0714 · Cited by 443
The papillomavirus E7 proteins
Roman, A., & Munger, K. (2013) · Virology · doi:10.1016/j.virol.2013.04.013 · Cited by 409
Intratumoral injection of Clostridium novyi -NT spores induces antitumor responses
Roberts, N. J., Zhang, L., Janku, F., Collins, A., Bai, R.-Y., Staedtke, V., Rusk, A. W., Tung, D., Miller, M., Roix, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008982 · Cited by 400
Noman, M. Z., Hasmim, M., Messai, Y., Terry, S., Kieda, C., Janji, B., & Chouaib, S. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00207.2015 · Cited by 400
Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases
Berman, T. A., & Schiller, J. T. (2017) · Cancer · doi:10.1002/cncr.30588 · Cited by 395
Stevanović, S., Pasetto, A., Helman, S. R., Gartner, J. J., Prickett, T. D., Howie, B., Robins, H. S., Robbins, P. F., Klebanoff, C. A., Rosenberg, S. A., et al. (2017) · Science · doi:10.1126/science.aak9510 · Cited by 383
Nakagawa, S., & Huibregtse, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8244-8253.2000 · Cited by 382
The role of integration in oncogenic progression of HPV-associated cancers
McBride, A. A., & Warburton, A. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006211 · Cited by 376
Duensing, S., & Münger, K. (2004) · International Journal of Cancer · doi:10.1002/ijc.11691 · Cited by 366
Goodwin, E. C., & DiMaio, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12513 · Cited by 362
Lee, S. S., Weiss, R. S., & Javier, R. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6670 · Cited by 356
Papillomavirus E6 oncoproteins
Vande Pol, S. B., & Klingelhutz, A. J. (2013) · Virology · doi:10.1016/j.virol.2013.04.026 · Cited by 346
DeFilippis, R. A., Goodwin, E. C., Wu, L., & DiMaio, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.2.1551-1563.2003 · Cited by 334
Hypoxia‐inducible factors in regulation of immune responses in tumour microenvironment
Kumar, V., & Gabrilovich, D. I. (2014) · Immunology · doi:10.1111/imm.12380 · Cited by 329
McLaughlin-Drubin, M. E., Crum, C. P., & Münger, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009933108 · Cited by 288
Butz, K., Ristriani, T., Hengstermann, A., Denk, C., Scheffner, M., & Hoppe-Seyler, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206894 · Cited by 283
Self-citationGlaunsinger, B. A., Lee, S. S., Thomas, M., Banks, L., & Javier, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203906 · Cited by 264
Viral oncoproteins target the DNA methyltransferases
Burgers, W. A., Blanchon, L., Pradhan, S., Launoit, Y. D., Kouzarides, T., & Fuks, F. (2007) · Oncogene · doi:10.1038/sj.onc.1209950 · Cited by 242
Butz, K., Denk, C., Ullmann, A., Scheffner, M., & Hoppe-Seyler, F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110538897 · Cited by 241
Self-citationJones, D. L., Thompson, D. A., & Münger, K. (1997) · Virology · doi:10.1006/viro.1997.8851 · Cited by 231
Modulation of type M 2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein
Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., Eigenbrodt, E., & Jansen-Dürr, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1291 · Cited by 223
Bernard, B., Bailly, C., Lenoir, M.-C., Darmon, M. Y., Thierry, F., & Yaniv, M. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4317-4324.1989 · Cited by 222
Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins
Zanier, K., Charbonnier, S., Sidi, A. O. M. O., McEwen, A. G., Ferrario, M. G., Poussin-Courmontagne, P., Cura, V., Brimer, N., Babah, K. O., Ansari, T., et al. (2013) · Science · doi:10.1126/science.1229934 · Cited by 222
Honegger, A., Schilling, D., Bastian, S., Sponagel, J., Kuryshev, V., Sültmann, H., Scheffner, M., Hoppe-Seyler, K., & Hoppe-Seyler, F. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004712 · Cited by 222
Self-citationmicroRNAs are biomarkers of oncogenic human papillomavirus infections
Wang, X., Wang, H.-K., Li, Y., Hafner, M., Banerjee, N. S., Tang, S., Briskin, D., Meyers, C., Chow, L. T., Xie, X., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401430111 · Cited by 212
Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21CIP-dependent pathways
Wells, S. I. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5762 · Cited by 207
White, E. A., Sowa, M. E., Tan, M. J. A., Jeudy, S., Hayes, S. D., Santha, S., Münger, K., Harper, J. W., & Howley, P. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116776109 · Cited by 198
White, E. A., Kramer, R. E., Tan, M. J. A., Hayes, S. D., Harper, J. W., & Howley, P. M. (2012) · Journal of Virology · doi:10.1128/jvi.02172-12 · Cited by 198
RNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa Cells
Hall, A. H. S., & Alexander, K. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.6066-6069.2003 · Cited by 196
Spangle, J. M., & Münger, K. (2010) · Journal of Virology · doi:10.1128/jvi.00974-10 · Cited by 189
Therapy of Human Papillomavirus-Related Disease
Stern, P. L., van der Burg, S. H., Hampson, I. N., Broker, T. R., Fiander, A., Lacey, C. J., Kitchener, H. C., & Einstein, M. H. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.091 · Cited by 180
Rapid induction of senescence in human cervical carcinoma cells
Goodwin, E. C., Yang, E., Lee, C.-J., Lee, H.-W., DiMaio, D., & Hwang, E.-S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10978 · Cited by 176
Geroconversion: irreversible step to cellular senescence
Blagosklonny, M. V. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985507 · Cited by 148
Bodily, J. M., Mehta, K. P. M., & Laimins, L. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2626 · Cited by 147
Next generation prophylactic human papillomavirus vaccines
Schiller, J. T., & Müller, M. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71179-9 · Cited by 147
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy
Ganti, K., Broniarczyk, J. K., Manoubi, W., Massimi, P., Mittal, S., Pim, D., Szalmás, A., Thatte, J. V., Thomas, M., Tomaić, V., et al. (2015) · Viruses · doi:10.3390/v7072785 · Cited by 144
Molden, T., Christiansen, I. K., Karlsen, F., Skomedal, H., Nygård, J. F., & Hagmar, B. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0410 · Cited by 144
Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy
Baran, N., & Konopleva, M. Y. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0895 · Cited by 143
Chaiwongkot, A., Vinokurova, S., Pientong, C., Ekalaksananan, T., Kongyingyoes, B., Kleebkaow, P., Chumworathayi, B., Patarapadungkit, N., Reuschenbach, M., & Doeberitz, M. V. K. (2012) · International Journal of Cancer · doi:10.1002/ijc.27906 · Cited by 136
Sotlar, K., Stubner, A., Diemer, D., Menton, S., Menton, M., Dietz, K., Wallwiener, D. R., Kandolf, R., & Bültmann, B. D. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20153 · Cited by 129
Häfner, N., Driesch, C., Gajda, M. R., Jansen, L., Kirchmayr, R., Runnebaum, I. B., & Dürst, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210791 · Cited by 126
Butz, K., & Hoppe‐Seyler, F. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6476-6486.1993 · Cited by 120
Self-citationNew highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer
Yamato, K., Yamada, T., Kizaki, M., Ui-Tei, K., Natori, Y., Fujino, M., Nishihara, T., Ikeda, Y., Nasu, Y., Saigo, K., et al. (2008) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701118 · Cited by 110
Honegger, A., Leitz, J., Bulkescher, J., Hoppe‐Seyler, K., & Hoppe‐Seyler, F. (2013) · International Journal of Cancer · doi:10.1002/ijc.28164 · Cited by 109
Self-citationRegulatory elements in the viral genome
Bernard, H. (2013) · Virology · doi:10.1016/j.virol.2013.04.035 · Cited by 107
Jung, H. M., Phillips, B. L., & Chan, E. K. L. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-80 · Cited by 105
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases
Skeate, J. G., Woodham, A. W., Einstein, M. H., Silva, D. M. D., & Kast, W. M. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1136039 · Cited by 100
Activation of the Enhancer of Zeste Homologue 2 Gene by the Human Papillomavirus E7 Oncoprotein
Holland, D., Hoppe-Seyler, K., Schuller, B., Lohrey, C., Maroldt, J., Dürst, M., & Hoppe-Seyler, F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1134 · Cited by 99
Self-citationGarcía-Carrancá, A. M., Thierry, F., & Yaniv, M. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4321-4330.1988 · Cited by 97
Jabbar, S. F., Abrams, L., Glick, A. B., & Lambert, P. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0023 · Cited by 93
Dooley, K. E., Warburton, A., & McBride, A. A. (2016) · mBio · doi:10.1128/mbio.01446-16 · Cited by 87
Hausen, H. Z. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90070-1 · Cited by 80
Human Papillomaviruses As Therapeutic Targets in Human Cancer
Hellner, K., & Münger, K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.2186 · Cited by 80
Identification and Characterization of Small Molecule Human Papillomavirus E6 Inhibitors
Malecka, K. A., Fera, D., Schultz, D., Hodawadekar, S. C., Reichman, M., Donover, P. S., Murphy, M. E., & Marmorstein, R. (2014) · ACS Chemical Biology · doi:10.1021/cb500229d · Cited by 79
Neveu, G., Cassonnet, P., Vidalain, P., Rolloy, C., Mendoza, J., Jones, L. M., Tangy, F., Muller, M., Demeret, C., Tafforeau, L., et al. (2012) · Methods · doi:10.1016/j.ymeth.2012.07.029 · Cited by 79
Association between hTERT activation by HPV E6 proteins and oncogenic risk
Doorslaer, K. V., & Burk, R. D. (2012) · Virology · doi:10.1016/j.virol.2012.08.006 · Cited by 77
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
Griffin, H. M., Elston, R., Jackson, D. J., Ansell, K. H., Coleman, M. M., Winter, G. P., & Doorbar, J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.077 · Cited by 76
Induction of dormancy in hypoxic human papillomavirus-positive cancer cells
Hoppe‐Seyler, K., Bossler, F., Lohrey, C., Bulkescher, J., Rösl, F., Jansen, L., Mayer, A., Vaupel, P. W., Dürst, M., & Hoppe‐Seyler, F. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615758114 · Cited by 75
Self-citationMagaldi, T. G., Almstead, L. L., Bellone, S., Prevatt, E. G., Santin, A. D., & DiMaio, D. (2011) · Virology · doi:10.1016/j.virol.2011.10.012 · Cited by 73
Thomas, M., Myers, M. P., Massimi, P., Guarnaccia, C., & Banks, L. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005766 · Cited by 72
LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism
Zeng, Q., Chen, J., Li, Y., Werle, K. D., Zhao, R.-X., Quan, C.-S., Wang, Y.-S., Zhai, Y.-X., Jw, W., Youssef, M., et al. (2016) · Oncogene · doi:10.1038/onc.2016.290 · Cited by 72
Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins
Harden, M. E., Prasad, N., Griffiths, A., & Munger, K. (2017) · mBio · doi:10.1128/mbio.02170-16 · Cited by 64
Pathophysiology of Solid Tumors
Vaupel, P. W. (2009) · Medical radiology · doi:10.1007/978-3-540-74386-6_4 · Cited by 59
Zanier, K., Stutz, C., Kintscher, S., Reinz, E., Sehr, P. A., Bulkescher, J., Hoppe‐Seyler, K., Travé, G., & Hoppe‐Seyler, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112514 · Cited by 56
Self-citationThe Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies
Molls, M., Anscher, M. S., Vaupel, P. W., & Nieder, C. (2009) · Medical radiology · doi:10.1007/978-3-540-74386-6 · Cited by 51
Hypoxia and Metabolism in Cancer
Bensaad, K., & Harris, A. L. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_1 · Cited by 50
Ganti, K., Massimi, P., Manzo-Merino, J., Tomaić, V., Pim, D., Playford, M. P., Lizano, M., Roberts, S., Kranjec, C., Doorbar, J., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005854 · Cited by 50
Inhibition of E6-induced Degradation of its Cellular Substrates by Novel Blocking Peptides
Grm, H. Š., Weber, M., Elston, R., McIntosh, P. B., Griffin, H. M., Banks, L., & Doorbar, J. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.079 · Cited by 46
Dymalla, S., Scheffner, M., Weber, E., Sehr, P. A., Lohrey, C., Hoppe‐Seyler, F., & Hoppe‐Seyler, K. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0432-1 · Cited by 37
Self-citationHPV E6 oncoprotein as a potential therapeutic target in HPV related cancers
Manzo-Merino, J., Thomas, M., Fuentes-González, A. M., Lizano, M., & Banks, L. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.832204 · Cited by 35
Ramirez, J., Poirson, J., Foltz, C., Chebaro, Y., Schrapp, M., Meyer, A., Bonetta, A., Forster, A., Jacob, Y., Masson, M., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201502646 · Cited by 34
Ch, Y., Filippova, M., Krstenansky, J. L., & Duerksen-Hughes, P. J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.391 · Cited by 34
Molecular Probing of the HPV-16 E6 Protein Alpha Helix Binding Groove with Small Molecule Inhibitors
Rietz, A., Petrov, D. P., Bartolowits, M. D., DeSmet, M. L., Davisson, V. J., & Androphy, E. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149845 · Cited by 33
Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker
Fontecha, N., Basaras, M., Hernáez, S., Andía, D., & Cisterna, R. (2016) · BMC Cancer · doi:10.1186/s12885-016-2885-x · Cited by 32
Emerging topics in human tumor virology
Hoppe‐Seyler, F., & Hoppe‐Seyler, K. (2011) · International Journal of Cancer · doi:10.1002/ijc.26087 · Cited by 25
Self-citationStutz, C., Reinz, E., Honegger, A., Bulkescher, J., Schweizer, J., Zanier, K., Travé, G., Lohrey, C., Hoppe‐Seyler, K., & Hoppe‐Seyler, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132339 · Cited by 21
Self-citation
Cited by
The Role of Zinc in Antiviral Immunity
Read, S. A., Obeid, S., Ahlenstiel, C., & Ahlenstiel, G. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz013 · Cited by 749
Chan, C. K., Aimagambetova, G., Ukybassova, T., Kongrtay, K., & Azizan, A. (2019) · Journal of Oncology · doi:10.1155/2019/3257939 · Cited by 494
CRISPR-Cas9 for cancer therapy: Opportunities and challenges
Chen, M., Mao, A., Xu, M., Weng, Q., Mao, J., & Ji, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.017 · Cited by 272
Practical Use of Immortalized Cells in Medicine: Current Advances and Future Perspectives
Voloshin, N., Tyurin-Kuzmin, P., Karagyaur, M., Akopyan, Z., & Kulebyakin, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612716 · Cited by 77
Miyauchi, S., Sanders, P. D., Guram, K., Kim, S. S., Paolini, F., Venuti, A., Cohen, E. E. W., Gutkind, J. S., Califano, J. A., & Sharabi, A. B. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1771 · Cited by 64
Metadata
- Authors
- Hoppe-Seyler, K., Bossler, F., Braun, J. A., Herrmann, A. L., & Hoppe-Seyler, F.
- Venue
- Trends in Microbiology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 26
- Issue
- 2
- Pages
- 158-168
- ISSN
- 0966-842X (ISSN-L)
- OpenAlex
- W2750092411
- Cited by
- 457
- References
- 105
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.